UiPath Stock News

Aging populations and wage inflation are making automation economically compelling across warehouses, factories, hospitals, and service industries. The robotics market encompasses a range of industries and niches, from mature surgical systems to warehouse automation and even humanoid platforms designed for household chores.

UiPath offers an AI-driven automation platform, targeting workflow efficiency and accessibility for a broad range of users. PATH is undervalued, trading at a forward P/E of 22, an 11% discount to the sector median, despite strong growth and AI tailwinds. I rate PATH as a Buy with a $17 price target, implying 20% upside and potential for market outperformance over the next 12 months.

After two years, I'm upgrading UiPath from "Hold" to "Buy," citing a fundamental flip driven by AI agentic automation momentum. PATH's Agentic Automation suite is driving customer growth, higher margins, and bullish earnings revisions, with strong momentum in ARR and profitability. The current Q3 consensus earnings estimate appears too pessimistic, creating a high probability of a significant e...

UiPath presents a compelling accumulation opportunity after recent profit-taking, with core RPA business strength and visible AI-driven growth catalysts. PATH's revenue growth has stabilized at double digits, with improving operating and free cash flow margins, supporting a maturing tech narrative and downside protection. Current valuations do not fully reflect AI optionality; conservative DCF ...

UiPath is rated a Buy due to its strategic shift towards integrating generative AI into its RPA platform, driving future growth. PATH's new partnerships with Snowflake, Google, Microsoft, and Nvidia position it as a leader in enterprise AI agent automation. Strong financials, consistent earnings beats, and upward analyst revisions support confidence in PATH's growth and profitability outlook.

Palantir is growing like a weed, but its valuations are getting overheated. UiPath faces tough near-term challenges, but its stock looks a lot cheaper.

UiPath and GitLab's stocks are both trading at cheap valuations. UiPath could be on the path to a big turnaround as it becomes an AI agent orchestration platform.

UiPath announced a number of new collaborations and products at its Fusion conference. Time magazine named its agentic automation one of the best inventions of the year.